Kingsford Pharmaceuticals

2600 Eastern Beltway

Dallas, Texas 75225
(214) 668-9234 (214) 668-2349 FAX

Contact: Casandra Canthal Public Relations Director, Kingsford

Pharmaceuticals

February 28, 2015

X23 Tablet to Cure West Nile Virus

(Dallas, Texas)--- Kingsford Pharmaceuticals is pleased to
announce the latest medical advancement in the fight
against West Nile Virus. X23 will completely rid the human
body of all traces of the virus when taken within two weeks
of infection. CEO Roberta Cruz-Suarez sees X23, as a
medical break through that will have profound implications
on human health. X23 has the potential to save thousands of
lives. Kingsford will be announcing the discovery of this
medication at its annual stockholders meeting on March 1,
2015.
While the FDA has not officially approved the medication,
CEO Suarez is confident that once the FDA testing begins in
two weeks X23 will quickly be approved and available for
distribution. The company is collaborating with the FDA
making sure all regulations and protocols are met in an effort
to not repeat the improper record-keeping occurrence in
1999. At the conclusion of the FDAs testing on the drug CEO
Suarez hopes that X23 can get into the hands of doctors
and nurses all over the world who will partner with us in the
fight against West Nile Virus.
Kingsford Pharmaceuticals was founded in Dallas in 1976.
With the assistance of several of the worlds leading
scientists, Kingsford has been able to create numerous
antidotes and medications that have saved the lives of

millions all over the world. Their scientists are consistently

experimenting with the latest technology and are always
conducting research determined to continue their endeavors
in medical advancements and stay ahead of their
competitors.